OXOID LIMITED

• ◆

  Material uncertainty over going concern

  The Directors have prepared the financial statements on a going concern basis because the Company continues to trade and there is no intention to cease operations. However, subsequent to the reporting date, Thermo Fisher Scientific Inc. entered into a definitive agreement to sell its Microbiology Division, including the Company, to Astorg. As these matters are outside the control of the current Directors, they have no visibility and are unable to obtain sufficient evidence regarding the purchaser's future intentions. Accordingly, these conditions represent a material uncertainty that may cast significant doubt upon the Company's ability to continue as a going concern.

• ·

  Going-concern uncertainty disclosed

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. OXOID LIMITED 1997-01-08 → present
2. PEWTER (NO.2) LIMITED 1996-12-17 → 1997-01-08
3. OXCO (NO 2) LIMITED 1996-12-09 → 1996-12-17

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

PricewaterhouseCoopers LLP

Audit opinion

Unqualified (clean)

Going concern

Material uncertainty disclosed

“The Directors have prepared the financial statements on a going concern basis because the Company continues to trade and there is no intention to cease operations. However, subsequent to the reporting date, Thermo Fisher Scientific Inc. entered into a definitive agreement to sell its Microbiology Division, including the Company, to Astorg. As these matters are outside the control of the current Directors, they have no visibility and are unable to obtain sufficient evidence regarding the purchaser's future intentions. Accordingly, these conditions represent a material uncertainty that may cast significant doubt upon the Company's ability to continue as a going concern.”

Group structure

1. OXOID LIMITED · parent
   1. G & M Procter Limited 100% · UK · manufacture of pharmaceutical products
   2. Thermo Fisher (Heysham) Limited 100% · UK · holding entity
   3. Avocado Research Chemicals Limited 100% · UK · manufacture of chemicals

Significant events

• “Subsequent to the reporting date as disclosed in Note 29, Thermo Fisher Scientific Inc. entered into a definitive agreement to sell its Microbiology Division, including the Company to Astorg, a private equity firm. The transaction is subject to customary regulatory approvals and other closing conditions and is expected to complete during the second half of 2026.”
• “Since February 28, 2026, a military conflict has been taking place between the USA and Israel on the one hand and Iran on the other (Middle East War). This also affects US military bases in other countries in the region. The armed conflict is increasing pressure on supply chains and energy costs and is leading to reactions on the goods and financial markets.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

18

last 12 months

Capital events

3

last 24 months

Officers appointed

0

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.